Trial intelligence / Profile preview

Dexibuprofen versus ibuprofen in children and adolescents with tonsillopharyngitis

2004-004267-30Phase 3Completed

Sponsor
Gebro Pharma
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexibuprofen and ibuprofen in tonsillopharyngitis (2 arms), sponsored by Gebro Pharma. Primary endpoints: SPID0-4 and TOTPAR0-4. Started Jun 2005; status: completed.

02

Drugs

dexibuprofenibuprofen
03

Conditions

tonsillopharyngitis

Beyond the preview

Go deeper on 2004-004267-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004267-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call